Research and Markets: Big Pharma Take Advantage of Reimbursement for

Research and Markets: Big Pharma Take Advantage of Reimbursement for

Filed under: drug rehab treatment options

Since the option of opting for money instead of medicine was provided under the program, a greater number of patients opted for the money. Those patients who opted for medicines got a chance to be treated by some of the best medicines available for …
Read more on The Herald | HeraldOnline.com

 

Complix Raises €12 Million (US.5 million) in Series B Round

Filed under: drug rehab treatment options

These data give us great confidence that our Alphabody platform can deliver the next generation drugs that the pharmaceutical industry is eagerly looking for to drive its growth and tackle a broad range of diseases where current treatment options are …
Read more on The Herald | HeraldOnline.com

 

NuPathe to Present ZECUITY Data at the 2013 International Headache Congress

Filed under: drug rehab treatment options

"These additional data show that ZECUITY is an easy-to-use new treatment option that is particularly well-suited for the millions of migraine patients who frequently suffer from debilitating migraine-related nausea along with their headache pain during …
Read more on Marketwire (press release)

 

Research and Markets: Inherited Orphan Blood Diseases Patients Face

Filed under: drug rehab treatment options

Research and Markets (http://www.researchandmarkets.com/research/tr2492/inherited_orphan) has announced the addition of the "Inherited Orphan Blood Disorders Therapeutics Market to 2019 – Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet …
Read more on Wall Street Journal (press release)